middle.news
How Australian Clinical Labs Powered 8.7% EBIT Growth Amid Market Headwinds
11:07pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
How Australian Clinical Labs Powered 8.7% EBIT Growth Amid Market Headwinds
11:07pm on Friday 29th of August, 2025 AEST
Key Points
6.4% revenue growth despite challenging market conditions
Underlying EBIT up 8.7%, with margin expansion to 9.2%
Full year dividend of 12.5 cents per share, fully franked
Returned $44 million to shareholders via dividends and buyback
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Australian Clinical Labs (ASX:ACL)
OPEN ARTICLE